Cargando…

Controlled attenuation parameters to assess liver steatosis in obese patients with polycystic ovary syndrome

OBJECTIVES: This study was performed to investigate the changes and influencing factors of liver controlled attenuation parameter (CAP) in obese patients with polycystic ovary syndrome (PCOS), and to determine the prevalence and risk factors of nonalcoholic fatty liver disease (NAFLD) in PCOS patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Dongxu, Nan, Nan, Bing, Hao, He, Bing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10501797/ https://www.ncbi.nlm.nih.gov/pubmed/37720537 http://dx.doi.org/10.3389/fendo.2023.1241734

Ejemplares similares

Current Perspectives on Nonalcoholic Fatty Liver Disease in Women with Polycystic Ovary Syndrome
por: Wang, Dongxu, et al.
Publicado: (2022)

Obesity and Outcome of Assisted Reproduction in Patients With Polycystic Ovary Syndrome
por: Tziomalos, Konstantinos, et al.
Publicado: (2018)

Comprehensive Assessment of the STIMs and Orais Expression in Polycystic Ovary Syndrome
por: Song, Tian, et al.
Publicado: (2022)

Kisspeptin and Polycystic Ovary Syndrome
por: Tang, Rong, et al.
Publicado: (2019)

Transient Elastography and Controlled Attenuation Parameter (CAP) in the Assessment of Liver Steatosis in Severe Adult Growth Hormone Deficiency
por: Carvalho-Furtado, Adriana Claudia Lopes, et al.
Publicado: (2019)

Corrigendum: Comprehensive assessment of the STIMs and Orais expression in polycystic ovary syndrome
por: Song, Tian, et al.
Publicado: (2022)

The role of the thyroid in polycystic ovary syndrome
por: Fan, Huanhuan, et al.
Publicado: (2023)

Editorial: Epigenetics of polycystic ovary syndrome
por: Parker, Jim, et al.
Publicado: (2023)

Correlation Between Fecal Metabolomics and Gut Microbiota in Obesity and Polycystic Ovary Syndrome
por: Zhou, Ling, et al.
Publicado: (2020)

Telomere Length Differently Associated to Obesity and Hyperandrogenism in Women With Polycystic Ovary Syndrome
por: Velazquez, Mariela Edith, et al.
Publicado: (2021)

The Lifestyle Modifications and Endometrial Proteome Changes of Women With Polycystic Ovary Syndrome and Obesity
por: Abdulkhalikova, D., et al.
Publicado: (2022)

Different sleep pattern in over-weight/obese women with polycystic ovary syndrome
por: Oberg, Emma, et al.
Publicado: (2023)

Effect of metformin versus metformin plus liraglutide on gonadal and metabolic profiles in overweight patients with polycystic ovary syndrome
por: Xing, Chuan, et al.
Publicado: (2022)

Hepatic steatosis in women with polycystic ovary syndrome
por: Hong, Xinyu, et al.
Publicado: (2023)

Lipid accumulation product independently correlate with hepatic steatosis quantified by controlled attenuation parameter in women with polycystic ovary syndrome
por: Zheng, Silan, et al.
Publicado: (2020)

Canagliflozin combined with metformin versus metformin monotherapy for endocrine and metabolic profiles in overweight and obese women with polycystic ovary syndrome: A single-center, open-labeled prospective randomized controlled trial
por: Zhang, Jiaqi, et al.
Publicado: (2022)

A bibliometric and visual analysis of obesity and polycystic ovary syndrome from 2012 to 2022
por: Luo, Ping, et al.
Publicado: (2022)

Effect of hyperlipidemia on the outcome of in vitro fertilization in non-obese patients with polycystic ovary syndrome
por: Yang, Fang, et al.
Publicado: (2023)

Sodium-glucose cotransporter-2 inhibitors for improving endocrine and metabolic profiles in overweight and obese individuals with polycystic ovary syndrome: a meta-analysis protocol
por: Zhang, Jiaqi, et al.
Publicado: (2022)

Effects of intestinal flora on polycystic ovary syndrome
por: Liu, Jiayue, et al.
Publicado: (2023)

SAT356 Predicting Nonalcoholic Fatty Liver Disease in Adolescent Girls with Polycystic Ovary Syndrome and Obesity
por: Lo, Jaclyn S, et al.
Publicado: (2023)

Polycystic Ovary Syndrome
por: Franks, Stephen
Publicado: (1998)

Obesity Exacerbates Irritable Bowel Syndrome-Related Sleep and Psychiatric Disorders in Women With Polycystic Ovary Syndrome
por: Tseng, Ping-Huei, et al.
Publicado: (2021)

Associations Between Asthma and Polycystic Ovary Syndrome: Current Perspectives
por: Xu, Yue, et al.
Publicado: (2022)

Genetic Rodent Models of Obesity-Associated Ovarian Dysfunction and Subfertility: Insights into Polycystic Ovary Syndrome
por: Huang-Doran, Isabel, et al.
Publicado: (2016)

High density lipoprotein-associated proteins in non-obese women with and without polycystic ovary syndrome
por: Butler, Alexandra E., et al.
Publicado: (2023)

Prevalence of hepatic steatosis in women with polycystic ovary syndrome
por: Karoli, Ritu, et al.
Publicado: (2013)

Effects of Melatonin Supplementation on Hormonal, Inflammatory, Genetic, and Oxidative Stress Parameters in Women With Polycystic Ovary Syndrome
por: Jamilian, Mehri, et al.
Publicado: (2019)

Editorial: Polycystic ovary syndrome (PCOS): Mechanism and management
por: Wang, Yishu, et al.
Publicado: (2022)

Cardiovascular disease risk in offspring of polycystic ovary syndrome
por: Shawky, Noha M.
Publicado: (2022)

Quantitative Proteomics Reveals That a Prognostic Signature of the Endometrium of the Polycystic Ovary Syndrome Women Based on Ferroptosis Proteins
por: Zhang, Jian, et al.
Publicado: (2022)

Systematical assessment of digit ratio in a female masculinization disease: polycystic ovary syndrome
por: Yan, Xueqi, et al.
Publicado: (2023)

The relationship between polycystic ovary syndrome and coronary heart disease: a bibliometric analysis
por: Liang, Xuzhi, et al.
Publicado: (2023)

Hepatic steatosis relates to gastrointestinal microbiota changes in obese girls with polycystic ovary syndrome
por: Jobira, Beza, et al.
Publicado: (2021)

Metformin Improves the Hepatic Steatosis Index in Non-Obese Patients with Polycystic Ovary Syndrome
por: Riemann, Annika, et al.
Publicado: (2022)

Endocrine and metabolic interactions in healthy pregnancies and hyperinsulinemic pregnancies affected by polycystic ovary syndrome, diabetes and obesity
por: Neven, Adriana C. H., et al.
Publicado: (2023)

New Therapeutic Approaches in Obesity and Metabolic Syndrome Associated with Polycystic Ovary Syndrome
por: Saleem, Fatima, et al.
Publicado: (2017)

Metformin improves polycystic ovary syndrome in mice by inhibiting ovarian ferroptosis
por: Peng, Qingjie, et al.
Publicado: (2023)

Personality and Psychiatric Disorders in Women Affected by Polycystic Ovary Syndrome
por: Scaruffi, Elisabetta, et al.
Publicado: (2014)

Role of Anti-Müllerian Hormone in the Pathogenesis of Polycystic Ovary Syndrome
por: Dewailly, Didier, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mqvbjdd5jm1pq755hfftkq294f